Integra Lifesciences Holdings Income Statement
IART / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Integra Lifesciences Holdings reported $1.6B in revenue and $516M in net loss for FY2025. Revenue has grown at a 5.4% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.6B | $1.5B | $1.6B | $1.5B | $1.4B | $1.5B | $1.5B | $1.2B | $992.1M | $882.7M | $796.7M | $696.8M | $732.1M | $780.1M |
| Cost of Revenue | $803.6M | $728.5M | $656.8M | $587.4M | $597.8M | $520.8M | $564.7M | $571.5M | $435.5M | $349.1M | $326.5M | $302.9M | $279.5M | $268.2M | $299.1M |
| Gross Profit | - | - | - | - | - | $851.0M | $952.9M | $900.9M | $752.7M | $643.0M | $556.2M | $493.8M | $116.4M | $121.5M | $116.1M |
| SG&A Expense | $699.7M | $717.0M | $656.6M | $616.3M | $637.4M | $594.5M | $687.6M | $690.7M | $624.1M | $455.6M | $415.8M | $375.5M | $332.2M | $305.1M | $358.1M |
| R&D Expense | $99.0M | $115.4M | $104.2M | $101.2M | $93.1M | $77.4M | $79.6M | $78.0M | $63.5M | $58.2M | $50.9M | $43.6M | $42.6M | $48.1M | $51.5M |
| Operating Income | -$493.4M | $28.4M | $111.5M | $238.9M | $197.2M | $151.4M | $93.8M | $111.0M | $44.8M | $115.3M | $79.6M | $67.9M | $35.4M | $98.7M | $54.9M |
| Interest Expense | - | - | $51.4M | $49.6M | $50.4M | $71.6M | $54.0M | $64.7M | $35.0M | $25.8M | $23.5M | $22.0M | $19.7M | $18.4M | $27.6M |
| Income Tax | -$47.0M | -$11.3M | $13.3M | $33.3M | $45.6M | -$40.4M | $9.9M | -$3.4M | -$53.4M | $15.8M | $53.8M | $9.3M | -$3.2M | $16.4M | $505.0K |
| Net Income | -$516.5M | -$6.9M | $67.7M | $180.6M | $169.1M | $133.9M | $50.2M | $60.8M | $64.7M | $74.6M | -$3.5M | $34.0M | -$21.1M | $65.7M | $28.0M |
| EPS (Basic) | $0.85 | $2.18 | $2.00 | $1.58 | $0.59 | $0.73 | $0.84 | $1.00 | $0.84 | $1.00 | -$0.74 | $1.46 | $0.97 | $2.21 | $1.75 |
| EPS (Diluted) | $0.84 | $2.16 | $1.98 | $1.57 | $0.58 | $0.72 | $0.82 | $0.94 | $0.82 | $0.94 | -$0.74 | $1.44 | $0.95 | $2.17 | $1.74 |
| Shares Outstanding | 80.3M | 83.5M | 85.5M | 85.2M | 86.5M | 84.0M | 79.1M | 79.2M | 79.1M | 79.2M | 28.8M | 28.5M | 29.5M | 30.1M | 29.3M |
| Gross Margin | - | - | - | - | - | 62.0% | 62.8% | 61.2% | 63.3% | 64.8% | 63.0% | 62.0% | 16.7% | 16.6% | 14.9% |
| Operating Margin | -30.2% | 1.8% | 7.2% | 15.3% | 12.8% | 11.0% | 6.2% | 7.5% | 3.8% | 11.6% | 9.0% | 8.5% | 5.1% | 13.5% | 7.0% |
| Profit Margin | -31.6% | -0.4% | 4.4% | 11.6% | 11.0% | 9.8% | 3.3% | 4.1% | 5.5% | 7.5% | -0.4% | 4.3% | -3.0% | 9.0% | 3.6% |